SlideShare a Scribd company logo
Incorporate Domestic and
International Regulations
for Effective GMP Auditing
Janeen Santarosa
Regulatory (Affairs)
Specialist II
Presentation Overview
• Best Practices for harmonization
• Domestic and international guidances,
standards and regulations
• Integrating valuable risk based and
sustainable practices
• Supplier audit practice tools
Copyright Nelson Laboratories
2011
2
Harmonization Objectives
FDA’s goals in participating in international
harmonization include:
• To safeguard U.S. public health
• To assure that consumer protection standards and
requirements are met
• To facilitate the availability of safe and effective
products
• To develop and utilize product standards and other
requirements more effectively
• To minimize or eliminate inconsistent standards
internationally
Copyright Nelson Laboratories
2011
3
Benefits…
• We are ultimately responsible for assuring the
quality and compliance of our products.
• Aligning goals = reaching high levels of
performance without excessive costs or
redundant or conflicting requirements.
• Avoid the risk of service/product failures.
• Ensure specifications match supplier capabilities
to avoid issues.
• Supplier Benefit: Increased knowledge and better
understanding of customer expectations.
Copyright Nelson Laboratories
2011
4
Harmonized Requirements
• Comparison Chart outlining supplier qualification
• Similarities but with different applications
include:
• ICH-Manufacturers of intermediates and/or API’s should
have a system(s) in place for evaluating suppliers of
critical material. Materials should be purchased against
an agreed specification from supplier or suppliers
approved by the quality units.
• GHTF-When selecting potential suppliers the
manufacturer should investigate their business and
operational capability. Select potential suppliers
according to predefined criteria and the results of
capability investigations.
Copyright Nelson Laboratories
2011
5
Best Practices
• Developing a risk based sustainable approach
• Systems for managing and controlling
suppliers include:
• Qualification
• Audits (paper/onsite), third-party certification)
• Assessments (intervals)
• Agreements (quality/change)
• Monitoring (continuous)
Copyright Nelson Laboratories
2011
6
Audits
• Comparison Chart outlining supplier audits
• Similarities but with different applications
include:
• GHTF - Depending on the risk of the supplied
product/service, the manufacturer may plan and
perform periodic supplier re-evaluations,
regardless of whether problems have been
identified.
• TGA - Period Review: As part of the qualification
process a program for Periodic Review should be
established.
Copyright Nelson Laboratories
2011 7
Audits
Base supplier audits on type of risk (e.g. service
provided, supplies purchased, third party
certifications).
Definitions:
• GHTF/SG4/N33 “critical supplier” is a supplier delivering materials,
components, or services that may influence the safety and
performance of the product.
• ICH Q7: “Critical describes a process step, process condition, test
requirement, or other relevant parameter or item that must be
controlled within predetermined criteria to ensure that the API
meets its specification”.
• ICH Q9: “Risk is the combination of the probability of occurrence of
harm and the severity of the harm to the patient or consumer”.
Copyright Nelson Laboratories
2011
8
Audits
• Rate supplier audits on risk-based process
approach.
• Risk level drives the relation of supply/supplier.
The level of action addresses the supplier
situation individually and provides measureable
controls around the supplier.
• Tailor internal resources: Identify supplier risk
during receipt inspection, QC verification,
in-process inspection and final inspection.
Copyright Nelson Laboratories
2011
9
Audits
Example of Risk Levels:
• Level 1: The highest risk suppliers that have a
critical impact on the quality or availability of your
product
• Level 2: Significant risk suppliers that have a direct
impact on your product, alternatives are available
• Level 3: Moderate risk suppliers that have an
indirect impact on the product
• Level 4: Low risk suppliers that have no product
impact
10
Copyright Nelson Laboratories
2011
Audits
Example: Supplier audits based on
risk level – Action
Copyright Nelson Laboratories
2011
11
Level 1 Action
High risk supplier/service provider On-site audit
Level 3 Action
Moderate risk supplier Written audit
Level 4 Action
Low risk supplier Limited assessment / Audit not
applicable
Audits
Audit Frequency
Audit frequency is established based on risk and
performance (annual, biennial, triennial)
Frequency may change based on detection inputs from
assessment tools.
Increase audit frequency for adverse findings
Dependent on the status of third party certifications
Monitor supplier certifications = ensure
qualification programs are maintained
Copyright Nelson Laboratories
2011
12
Assessments
Copyright Nelson Laboratories
2011
13
Assessments
• Comparison Chart outlining supplier assessments
• Similarities but with different applications
include:
• ICH Q10-Monitor and review the performance of the
contract acceptor or the quality of the material from
the provider
• EU Volume 4 Part II-Have system for evaluating
suppliers of critical materials, monitor
• GHTF-Depending on risk of suppliers may plan and
perform periodic re-evaluations
Copyright Nelson Laboratories
2011
14
Agreements
• Agreements ensure the quality of purchased
products/services.
• Quality Agreements = Agree to the QMS
expectations, define responsibility
• Change Agreements = Notification requirements
of changes in order to assess impact to your
process/product.
• Service Agreements
• Purchase Order
Copyright Nelson Laboratories
2011
15
Agreements
• Comparison Chart outlining supplier agreements
• Similarities but with different applications
include:
• EU Volume 4 Part II-Formal agreement that defines/details
GMP responsibilities, quality measures of each party
• 21 CFR 820.50-Establish and maintain purchasing data with
specified requirements, notification of change agreements
• Health Canada-Written agreement outlining the specific
responsibilities of each party involved. Specify that the raw
material vendor must inform the drug fabricator of any
changes in the processing or specifications of the raw
material.
Copyright Nelson Laboratories
2011
16
Supplier Rating
• Supplier Scorecard results in improved supplier
performance, minimizes risk and sustains the
supply base.
• Develop scorecards with corporate
goals/objectives in mind.
• Quality, compliance, service, on-time delivery, cost
• “Where performance is measured, performance
improves”.
Copyright Nelson Laboratories
2011
17
Supplier Rating
• Supplier scorecards are used to measure and
monitor supplier performance.
• Identify attributes, agreements, factors and attribute
ratings
• Ensure the “highest factor” is what is most important
to your business needs
• Establish ratings: 90-100=Excellent,
75-89=Satisfactory, less than
75=Unsatisfactory
• Identify corrective action if applicable
Copyright Nelson Laboratories
2011
18
Supplier Rating
Copyright Nelson Laboratories
2011
19
Integrating valuable risk based and
sustainable practices
• Ensure process is sustainable with growth of
supplier base and adheres to standards
necessary to support quality and compliance.
• Pre-defined decision tree for consistent
determinations and justifications
• Risk based decision tree helps maintain
consistency and provides justification as to why
the audit type, or lack thereof is chosen.
Copyright Nelson Laboratories
2011
20
Integrating valuable risk based and
sustainable practices
Example: Decision Tree
•EXAMPLE
Copyright Nelson Laboratories
2011
21
Risk Assessment for Calibration Subcontractor Action
Certified to ISO 17025? Yes= Obtain cert for file
No= Written audit
Risk Assessment for Critical Component Action
Custom Built product? Yes=On-site audit
No= Go to next question
Certified to ISO? (applicable standard) Yes= Obtain cert for file
No= Written audit
Summary of Tools
• Objectives and goals
• Audits, assessments, agreements
• Risk Management: Ongoing supplier monitoring
• Audit selection based on supplier risk profile
• Supplier rating (Scorecard)
• Comparison tables
• Domestic and international reference tool
Copyright Nelson Laboratories
2011
22
Domestic and International
References
• GHTF/SG3/N17:2008- Control of Suppliers
• GHTF/SG3/N15R8- Risk Management Principles in a QMS
• GHTF/SG4/N84:2010 Guidelines for Regulatory Auditing of Quality Management Systems of
Medical Device Manufacturers Part 5: Audits of Manufacturer Control of Suppliers
• Health Canada - Good Manufacturing Practices (GMP) Guidelines GUI-001
• ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
• ICH Q10 Pharmaceutical Quality System
• EU Guidelines to GMP Part II Basic Requirements for Active Substances used as Starting
Materials
• ISO 13485 (Harmonized quality system standard adopted in Europe for medical devices)
• ISO 9000:2008 Principle 8: Mutually beneficial supplier relationships
• Japan Pharmaceutical Affairs Law (JPAL Ordinance 169)
• 21 CFR Part 210/211 21 CFR 820 Quality System Regulation(QSR)
• FDA’s “Guidance for Industry Quality Systems Approach to Pharmaceutical cGMP Regulations,
• Australian Government- Technical Guidance on the Interpretation of Manufacturing
Standards
• PIC/S Guide to Good Manufacturing Practice for Medicinal Products
Copyright Nelson Laboratories
2011
23
Questions?
Contact information:
Janeen Santarosa
Nelson Laboratories , Inc.
Phone: (801) 290-7671
jsantarosa@nelsonlabs.com
Thank you!
Copyright Nelson Laboratories
2011
24

More Related Content

What's hot

GMP- APQR Training
GMP- APQR TrainingGMP- APQR Training
GMP- APQR Training
Dr. Amsavel A
 
TOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENTTOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENT
Pharmaceutical
 
Regulatory aspect of pharmaceutical change control system
Regulatory aspect of pharmaceutical  change control systemRegulatory aspect of pharmaceutical  change control system
Regulatory aspect of pharmaceutical change control system
DeveshDRA
 
Validation Master Plan
Validation Master PlanValidation Master Plan
Validation Master Plan
Institute of Validation Technology
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fda
Fasika Mekete
 
Effective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data TrendingEffective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data Trending
Institute of Validation Technology
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
Pavisara
 
concept of validation
concept of validationconcept of validation
concept of validation
prashik shimpi
 
Validation of pharmaceutical dosage form
Validation of pharmaceutical dosage formValidation of pharmaceutical dosage form
Validation of pharmaceutical dosage form
anurag chanda
 
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment
Pharmaceutical
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
Atul Adhikari
 
Validation (intro, scope, merits, ich, who guidelines)
Validation (intro, scope, merits, ich, who guidelines)Validation (intro, scope, merits, ich, who guidelines)
Validation (intro, scope, merits, ich, who guidelines)
PRAJAKTASAWANT33
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHA
Dhiraj Shrestha
 

What's hot (20)

GMP- APQR Training
GMP- APQR TrainingGMP- APQR Training
GMP- APQR Training
 
Implement Process Validation
Implement Process ValidationImplement Process Validation
Implement Process Validation
 
TOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENTTOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENT
 
Regulatory aspect of pharmaceutical change control system
Regulatory aspect of pharmaceutical  change control systemRegulatory aspect of pharmaceutical  change control system
Regulatory aspect of pharmaceutical change control system
 
Validation Master Plan
Validation Master PlanValidation Master Plan
Validation Master Plan
 
Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fda
 
Effective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data TrendingEffective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data Trending
 
Validation boot camp 2
Validation boot camp 2Validation boot camp 2
Validation boot camp 2
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
 
Quality audit
Quality auditQuality audit
Quality audit
 
concept of validation
concept of validationconcept of validation
concept of validation
 
Validation of pharmaceutical dosage form
Validation of pharmaceutical dosage formValidation of pharmaceutical dosage form
Validation of pharmaceutical dosage form
 
Change control
Change controlChange control
Change control
 
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Vallidation
VallidationVallidation
Vallidation
 
Validation (intro, scope, merits, ich, who guidelines)
Validation (intro, scope, merits, ich, who guidelines)Validation (intro, scope, merits, ich, who guidelines)
Validation (intro, scope, merits, ich, who guidelines)
 
Process Validation Guidances FDA and Global
Process Validation Guidances FDA and GlobalProcess Validation Guidances FDA and Global
Process Validation Guidances FDA and Global
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHA
 

Viewers also liked

CPS Council Presentation May 2016
CPS Council Presentation May 2016CPS Council Presentation May 2016
CPS Council Presentation May 2016
Community Pharmacy Scotland
 
The Work of the General Pharmaceutical Council
The Work of the General Pharmaceutical CouncilThe Work of the General Pharmaceutical Council
The Work of the General Pharmaceutical CouncilIMI PQ NET Romania
 
What are Supergenerics
What are SupergenericsWhat are Supergenerics
What are Supergenerics
Anthony Melvin Crasto Ph.D
 
Charlotte City Council Meeting Minutes, January 26, 2009
Charlotte City Council Meeting Minutes, January 26, 2009Charlotte City Council Meeting Minutes, January 26, 2009
Charlotte City Council Meeting Minutes, January 26, 2009Daniel X. O'Neil
 
Bioanalytical method validation guidelines for ligand binding assays
Bioanalytical method validation guidelines for ligand binding assaysBioanalytical method validation guidelines for ligand binding assays
Bioanalytical method validation guidelines for ligand binding assays
SHANE_LOBO145
 
Validation Boot Camp
Validation Boot CampValidation Boot Camp
CPS Council Meeting - November 2016
CPS Council Meeting - November 2016CPS Council Meeting - November 2016
CPS Council Meeting - November 2016
Kirsten Crawford
 
Pharmaceutical Product & Process Design & Quality
Pharmaceutical Product & Process Design & QualityPharmaceutical Product & Process Design & Quality
Pharmaceutical Product & Process Design & Quality
Ajaz Hussain
 
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & ValidationNew EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
GMP EDUCATION : Not for Profit Organization
 
US FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process VerificationUS FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process Verification
GMP EDUCATION : Not for Profit Organization
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
Ajaz Hussain
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
GMP EDUCATION : Not for Profit Organization
 
Minute by Minute: Learning the Skill of Taking Meeting Minutes
Minute by Minute: Learning the Skill of Taking Meeting MinutesMinute by Minute: Learning the Skill of Taking Meeting Minutes
Minute by Minute: Learning the Skill of Taking Meeting Minutes
Beckie Layton
 
Drug discovery hit to lead
Drug discovery hit to leadDrug discovery hit to lead
Drug discovery hit to lead
Anthony Melvin Crasto Ph.D
 
Leadership Deveopment Brochure
Leadership Deveopment BrochureLeadership Deveopment Brochure
Leadership Deveopment Brochure
Laurence Yap M.A. (UM) CHRM
 
Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
GMP EDUCATION : Not for Profit Organization
 

Viewers also liked (20)

Statistical controls for qc
Statistical controls for qcStatistical controls for qc
Statistical controls for qc
 
Vanderbilt b
Vanderbilt bVanderbilt b
Vanderbilt b
 
Statistical control to monitor
Statistical control to monitorStatistical control to monitor
Statistical control to monitor
 
CPS Council Presentation May 2016
CPS Council Presentation May 2016CPS Council Presentation May 2016
CPS Council Presentation May 2016
 
The Work of the General Pharmaceutical Council
The Work of the General Pharmaceutical CouncilThe Work of the General Pharmaceutical Council
The Work of the General Pharmaceutical Council
 
What are Supergenerics
What are SupergenericsWhat are Supergenerics
What are Supergenerics
 
Charlotte City Council Meeting Minutes, January 26, 2009
Charlotte City Council Meeting Minutes, January 26, 2009Charlotte City Council Meeting Minutes, January 26, 2009
Charlotte City Council Meeting Minutes, January 26, 2009
 
Bioanalytical method validation guidelines for ligand binding assays
Bioanalytical method validation guidelines for ligand binding assaysBioanalytical method validation guidelines for ligand binding assays
Bioanalytical method validation guidelines for ligand binding assays
 
Validation Boot Camp
Validation Boot CampValidation Boot Camp
Validation Boot Camp
 
CPS Council Meeting - November 2016
CPS Council Meeting - November 2016CPS Council Meeting - November 2016
CPS Council Meeting - November 2016
 
Pharmaceutical Product & Process Design & Quality
Pharmaceutical Product & Process Design & QualityPharmaceutical Product & Process Design & Quality
Pharmaceutical Product & Process Design & Quality
 
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & ValidationNew EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
 
US FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process VerificationUS FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process Verification
 
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
 
Minute by Minute: Learning the Skill of Taking Meeting Minutes
Minute by Minute: Learning the Skill of Taking Meeting MinutesMinute by Minute: Learning the Skill of Taking Meeting Minutes
Minute by Minute: Learning the Skill of Taking Meeting Minutes
 
Drug discovery hit to lead
Drug discovery hit to leadDrug discovery hit to lead
Drug discovery hit to lead
 
Gamp5 new
Gamp5 newGamp5 new
Gamp5 new
 
Leadership Deveopment Brochure
Leadership Deveopment BrochureLeadership Deveopment Brochure
Leadership Deveopment Brochure
 
Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
 

Similar to Incorporate Domestic and International Regulations for Effective GMP Auditing

Vendor selection
Vendor selectionVendor selection
Vendor selection
aqsa fatima
 
Quality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticalsQuality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticals
Anvita Bharati
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptx
ssuserd2507a
 
vender certification.ppsx
vender certification.ppsxvender certification.ppsx
vender certification.ppsx
Rajesh Raut
 
Cqe preparation | supplier management
Cqe preparation | supplier managementCqe preparation | supplier management
Cqe preparation | supplier management
Eng. Hosam Abd Al-Galeil (CMQ/OE)
 
SAI Global Webinar: BRC Food Safety Issue 8
SAI Global Webinar: BRC Food Safety Issue 8SAI Global Webinar: BRC Food Safety Issue 8
SAI Global Webinar: BRC Food Safety Issue 8
Switzerland09
 
QUALITY AUDITS
QUALITY AUDITSQUALITY AUDITS
QUALITY AUDITS
Mcpl Moshi
 
Auditing in pharmacutical industries
Auditing in pharmacutical industriesAuditing in pharmacutical industries
Auditing in pharmacutical industries
Priyanka Kandhare
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
amol dighe
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
amol dighe
 
Vendor certification
Vendor certificationVendor certification
Vendor certification
Yachita Rajwadwala
 
Audits
AuditsAudits
Audits
Swathi P
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
ShihabPatel
 
vendorqualification-180226hhhhjjj172821.pdf
vendorqualification-180226hhhhjjj172821.pdfvendorqualification-180226hhhhjjj172821.pdf
vendorqualification-180226hhhhjjj172821.pdf
Vaibhavwagh48
 
quality-metrics-1.pdf
quality-metrics-1.pdfquality-metrics-1.pdf
quality-metrics-1.pdf
reza684755
 
Introduction types, Objectives, Management of audit, Responsibilities, Planni...
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Introduction types, Objectives, Management of audit, Responsibilities, Planni...
Introduction types, Objectives, Management of audit, Responsibilities, Planni...
Kunal10679
 
Introduction to CMMI-DEV v1.3 - Day 2
Introduction to CMMI-DEV v1.3  - Day 2Introduction to CMMI-DEV v1.3  - Day 2
Introduction to CMMI-DEV v1.3 - Day 2
Sherif Salah, MBA, ITIL, CMMI, MCSA, TQM
 
Quality managment
Quality managmentQuality managment
Quality managment
Ankit
 
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTIONPHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
Princy Agarwal
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
Deekshitha HS
 

Similar to Incorporate Domestic and International Regulations for Effective GMP Auditing (20)

Vendor selection
Vendor selectionVendor selection
Vendor selection
 
Quality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticalsQuality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticals
 
good laboratory practices.pptx
good laboratory practices.pptxgood laboratory practices.pptx
good laboratory practices.pptx
 
vender certification.ppsx
vender certification.ppsxvender certification.ppsx
vender certification.ppsx
 
Cqe preparation | supplier management
Cqe preparation | supplier managementCqe preparation | supplier management
Cqe preparation | supplier management
 
SAI Global Webinar: BRC Food Safety Issue 8
SAI Global Webinar: BRC Food Safety Issue 8SAI Global Webinar: BRC Food Safety Issue 8
SAI Global Webinar: BRC Food Safety Issue 8
 
QUALITY AUDITS
QUALITY AUDITSQUALITY AUDITS
QUALITY AUDITS
 
Auditing in pharmacutical industries
Auditing in pharmacutical industriesAuditing in pharmacutical industries
Auditing in pharmacutical industries
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Vendor certification
Vendor certificationVendor certification
Vendor certification
 
Audits
AuditsAudits
Audits
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
 
vendorqualification-180226hhhhjjj172821.pdf
vendorqualification-180226hhhhjjj172821.pdfvendorqualification-180226hhhhjjj172821.pdf
vendorqualification-180226hhhhjjj172821.pdf
 
quality-metrics-1.pdf
quality-metrics-1.pdfquality-metrics-1.pdf
quality-metrics-1.pdf
 
Introduction types, Objectives, Management of audit, Responsibilities, Planni...
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Introduction types, Objectives, Management of audit, Responsibilities, Planni...
Introduction types, Objectives, Management of audit, Responsibilities, Planni...
 
Introduction to CMMI-DEV v1.3 - Day 2
Introduction to CMMI-DEV v1.3  - Day 2Introduction to CMMI-DEV v1.3  - Day 2
Introduction to CMMI-DEV v1.3 - Day 2
 
Quality managment
Quality managmentQuality managment
Quality managment
 
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTIONPHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
PHARMACEUTICAL CALIBRATION, QUALIFICATION AND VALIDATION: AN INTRODUCTION
 
Vendor qualification
Vendor qualificationVendor qualification
Vendor qualification
 

More from Institute of Validation Technology

Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...
Institute of Validation Technology
 
Lifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning ValidationLifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning Validation
Institute of Validation Technology
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the Cloud
Institute of Validation Technology
 
Applying QbD to Biotech Process Validation
Applying QbD to Biotech Process ValidationApplying QbD to Biotech Process Validation
Applying QbD to Biotech Process Validation
Institute of Validation Technology
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Institute of Validation Technology
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical Development
Institute of Validation Technology
 
Determine Exceptions to Validation
Determine Exceptions to ValidationDetermine Exceptions to Validation
Determine Exceptions to Validation
Institute of Validation Technology
 
Conduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation ProgrammeConduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation Programme
Institute of Validation Technology
 
FDA Inspection
FDA InspectionFDA Inspection
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process Validation
Institute of Validation Technology
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
Institute of Validation Technology
 
Setting Biological Process Specifications
Setting Biological Process SpecificationsSetting Biological Process Specifications
Setting Biological Process Specifications
Institute of Validation Technology
 
Handling deviations & unexpected results during method validation
Handling deviations & unexpected results during method validationHandling deviations & unexpected results during method validation
Handling deviations & unexpected results during method validation
Institute of Validation Technology
 
Regulatory Considerations for use of Cloud Computing and SaaS Environments
Regulatory Considerations for use of Cloud Computing and SaaS EnvironmentsRegulatory Considerations for use of Cloud Computing and SaaS Environments
Regulatory Considerations for use of Cloud Computing and SaaS Environments
Institute of Validation Technology
 
Implementing a QbD program to make Process Validation a Lifestyle
Implementing a QbD program to make Process Validation a LifestyleImplementing a QbD program to make Process Validation a Lifestyle
Implementing a QbD program to make Process Validation a Lifestyle
Institute of Validation Technology
 
Apply Risk Management to Computerized and Automated Systems
Apply Risk Management to Computerized and Automated SystemsApply Risk Management to Computerized and Automated Systems
Apply Risk Management to Computerized and Automated Systems
Institute of Validation Technology
 
CAPA: A Risk Mitigating Quality System
CAPA: A Risk Mitigating Quality SystemCAPA: A Risk Mitigating Quality System
CAPA: A Risk Mitigating Quality System
Institute of Validation Technology
 

More from Institute of Validation Technology (20)

Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...
 
Lifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning ValidationLifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning Validation
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the Cloud
 
Applying QbD to Biotech Process Validation
Applying QbD to Biotech Process ValidationApplying QbD to Biotech Process Validation
Applying QbD to Biotech Process Validation
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical Development
 
Determine Exceptions to Validation
Determine Exceptions to ValidationDetermine Exceptions to Validation
Determine Exceptions to Validation
 
Conduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation ProgrammeConduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation Programme
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process Validation
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
 
Setting Biological Process Specifications
Setting Biological Process SpecificationsSetting Biological Process Specifications
Setting Biological Process Specifications
 
Method Transfer Crossing Multiple Borders
Method Transfer Crossing Multiple BordersMethod Transfer Crossing Multiple Borders
Method Transfer Crossing Multiple Borders
 
Handling deviations & unexpected results during method validation
Handling deviations & unexpected results during method validationHandling deviations & unexpected results during method validation
Handling deviations & unexpected results during method validation
 
Regulatory Considerations for use of Cloud Computing and SaaS Environments
Regulatory Considerations for use of Cloud Computing and SaaS EnvironmentsRegulatory Considerations for use of Cloud Computing and SaaS Environments
Regulatory Considerations for use of Cloud Computing and SaaS Environments
 
Implementing a QbD program to make Process Validation a Lifestyle
Implementing a QbD program to make Process Validation a LifestyleImplementing a QbD program to make Process Validation a Lifestyle
Implementing a QbD program to make Process Validation a Lifestyle
 
FDA 21 CFR Part 11 and Related Regulations and Guidances
FDA 21 CFR Part 11 and Related Regulations and GuidancesFDA 21 CFR Part 11 and Related Regulations and Guidances
FDA 21 CFR Part 11 and Related Regulations and Guidances
 
Apply Risk Management to Computerized and Automated Systems
Apply Risk Management to Computerized and Automated SystemsApply Risk Management to Computerized and Automated Systems
Apply Risk Management to Computerized and Automated Systems
 
CAPA: A Risk Mitigating Quality System
CAPA: A Risk Mitigating Quality SystemCAPA: A Risk Mitigating Quality System
CAPA: A Risk Mitigating Quality System
 
Know the Global Regulations for Change Control
Know the Global Regulations for Change ControlKnow the Global Regulations for Change Control
Know the Global Regulations for Change Control
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Incorporate Domestic and International Regulations for Effective GMP Auditing

  • 1. Incorporate Domestic and International Regulations for Effective GMP Auditing Janeen Santarosa Regulatory (Affairs) Specialist II
  • 2. Presentation Overview • Best Practices for harmonization • Domestic and international guidances, standards and regulations • Integrating valuable risk based and sustainable practices • Supplier audit practice tools Copyright Nelson Laboratories 2011 2
  • 3. Harmonization Objectives FDA’s goals in participating in international harmonization include: • To safeguard U.S. public health • To assure that consumer protection standards and requirements are met • To facilitate the availability of safe and effective products • To develop and utilize product standards and other requirements more effectively • To minimize or eliminate inconsistent standards internationally Copyright Nelson Laboratories 2011 3
  • 4. Benefits… • We are ultimately responsible for assuring the quality and compliance of our products. • Aligning goals = reaching high levels of performance without excessive costs or redundant or conflicting requirements. • Avoid the risk of service/product failures. • Ensure specifications match supplier capabilities to avoid issues. • Supplier Benefit: Increased knowledge and better understanding of customer expectations. Copyright Nelson Laboratories 2011 4
  • 5. Harmonized Requirements • Comparison Chart outlining supplier qualification • Similarities but with different applications include: • ICH-Manufacturers of intermediates and/or API’s should have a system(s) in place for evaluating suppliers of critical material. Materials should be purchased against an agreed specification from supplier or suppliers approved by the quality units. • GHTF-When selecting potential suppliers the manufacturer should investigate their business and operational capability. Select potential suppliers according to predefined criteria and the results of capability investigations. Copyright Nelson Laboratories 2011 5
  • 6. Best Practices • Developing a risk based sustainable approach • Systems for managing and controlling suppliers include: • Qualification • Audits (paper/onsite), third-party certification) • Assessments (intervals) • Agreements (quality/change) • Monitoring (continuous) Copyright Nelson Laboratories 2011 6
  • 7. Audits • Comparison Chart outlining supplier audits • Similarities but with different applications include: • GHTF - Depending on the risk of the supplied product/service, the manufacturer may plan and perform periodic supplier re-evaluations, regardless of whether problems have been identified. • TGA - Period Review: As part of the qualification process a program for Periodic Review should be established. Copyright Nelson Laboratories 2011 7
  • 8. Audits Base supplier audits on type of risk (e.g. service provided, supplies purchased, third party certifications). Definitions: • GHTF/SG4/N33 “critical supplier” is a supplier delivering materials, components, or services that may influence the safety and performance of the product. • ICH Q7: “Critical describes a process step, process condition, test requirement, or other relevant parameter or item that must be controlled within predetermined criteria to ensure that the API meets its specification”. • ICH Q9: “Risk is the combination of the probability of occurrence of harm and the severity of the harm to the patient or consumer”. Copyright Nelson Laboratories 2011 8
  • 9. Audits • Rate supplier audits on risk-based process approach. • Risk level drives the relation of supply/supplier. The level of action addresses the supplier situation individually and provides measureable controls around the supplier. • Tailor internal resources: Identify supplier risk during receipt inspection, QC verification, in-process inspection and final inspection. Copyright Nelson Laboratories 2011 9
  • 10. Audits Example of Risk Levels: • Level 1: The highest risk suppliers that have a critical impact on the quality or availability of your product • Level 2: Significant risk suppliers that have a direct impact on your product, alternatives are available • Level 3: Moderate risk suppliers that have an indirect impact on the product • Level 4: Low risk suppliers that have no product impact 10 Copyright Nelson Laboratories 2011
  • 11. Audits Example: Supplier audits based on risk level – Action Copyright Nelson Laboratories 2011 11 Level 1 Action High risk supplier/service provider On-site audit Level 3 Action Moderate risk supplier Written audit Level 4 Action Low risk supplier Limited assessment / Audit not applicable
  • 12. Audits Audit Frequency Audit frequency is established based on risk and performance (annual, biennial, triennial) Frequency may change based on detection inputs from assessment tools. Increase audit frequency for adverse findings Dependent on the status of third party certifications Monitor supplier certifications = ensure qualification programs are maintained Copyright Nelson Laboratories 2011 12
  • 14. Assessments • Comparison Chart outlining supplier assessments • Similarities but with different applications include: • ICH Q10-Monitor and review the performance of the contract acceptor or the quality of the material from the provider • EU Volume 4 Part II-Have system for evaluating suppliers of critical materials, monitor • GHTF-Depending on risk of suppliers may plan and perform periodic re-evaluations Copyright Nelson Laboratories 2011 14
  • 15. Agreements • Agreements ensure the quality of purchased products/services. • Quality Agreements = Agree to the QMS expectations, define responsibility • Change Agreements = Notification requirements of changes in order to assess impact to your process/product. • Service Agreements • Purchase Order Copyright Nelson Laboratories 2011 15
  • 16. Agreements • Comparison Chart outlining supplier agreements • Similarities but with different applications include: • EU Volume 4 Part II-Formal agreement that defines/details GMP responsibilities, quality measures of each party • 21 CFR 820.50-Establish and maintain purchasing data with specified requirements, notification of change agreements • Health Canada-Written agreement outlining the specific responsibilities of each party involved. Specify that the raw material vendor must inform the drug fabricator of any changes in the processing or specifications of the raw material. Copyright Nelson Laboratories 2011 16
  • 17. Supplier Rating • Supplier Scorecard results in improved supplier performance, minimizes risk and sustains the supply base. • Develop scorecards with corporate goals/objectives in mind. • Quality, compliance, service, on-time delivery, cost • “Where performance is measured, performance improves”. Copyright Nelson Laboratories 2011 17
  • 18. Supplier Rating • Supplier scorecards are used to measure and monitor supplier performance. • Identify attributes, agreements, factors and attribute ratings • Ensure the “highest factor” is what is most important to your business needs • Establish ratings: 90-100=Excellent, 75-89=Satisfactory, less than 75=Unsatisfactory • Identify corrective action if applicable Copyright Nelson Laboratories 2011 18
  • 19. Supplier Rating Copyright Nelson Laboratories 2011 19
  • 20. Integrating valuable risk based and sustainable practices • Ensure process is sustainable with growth of supplier base and adheres to standards necessary to support quality and compliance. • Pre-defined decision tree for consistent determinations and justifications • Risk based decision tree helps maintain consistency and provides justification as to why the audit type, or lack thereof is chosen. Copyright Nelson Laboratories 2011 20
  • 21. Integrating valuable risk based and sustainable practices Example: Decision Tree •EXAMPLE Copyright Nelson Laboratories 2011 21 Risk Assessment for Calibration Subcontractor Action Certified to ISO 17025? Yes= Obtain cert for file No= Written audit Risk Assessment for Critical Component Action Custom Built product? Yes=On-site audit No= Go to next question Certified to ISO? (applicable standard) Yes= Obtain cert for file No= Written audit
  • 22. Summary of Tools • Objectives and goals • Audits, assessments, agreements • Risk Management: Ongoing supplier monitoring • Audit selection based on supplier risk profile • Supplier rating (Scorecard) • Comparison tables • Domestic and international reference tool Copyright Nelson Laboratories 2011 22
  • 23. Domestic and International References • GHTF/SG3/N17:2008- Control of Suppliers • GHTF/SG3/N15R8- Risk Management Principles in a QMS • GHTF/SG4/N84:2010 Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers Part 5: Audits of Manufacturer Control of Suppliers • Health Canada - Good Manufacturing Practices (GMP) Guidelines GUI-001 • ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients • ICH Q10 Pharmaceutical Quality System • EU Guidelines to GMP Part II Basic Requirements for Active Substances used as Starting Materials • ISO 13485 (Harmonized quality system standard adopted in Europe for medical devices) • ISO 9000:2008 Principle 8: Mutually beneficial supplier relationships • Japan Pharmaceutical Affairs Law (JPAL Ordinance 169) • 21 CFR Part 210/211 21 CFR 820 Quality System Regulation(QSR) • FDA’s “Guidance for Industry Quality Systems Approach to Pharmaceutical cGMP Regulations, • Australian Government- Technical Guidance on the Interpretation of Manufacturing Standards • PIC/S Guide to Good Manufacturing Practice for Medicinal Products Copyright Nelson Laboratories 2011 23
  • 24. Questions? Contact information: Janeen Santarosa Nelson Laboratories , Inc. Phone: (801) 290-7671 jsantarosa@nelsonlabs.com Thank you! Copyright Nelson Laboratories 2011 24